Patents by Inventor Mohamad JAMILUDDIN

Mohamad JAMILUDDIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lentiviral vectors for expression of hepatitis B virus (HBV) antigens
    Patent number: 10864265
    Abstract: The invention relates to nucleic acids, including lentiviral vectors and lentiviral vector particles, encoding at least one Hepatitis B virus (HBV) envelop surface of genotypes A and/or C antigen, at least one polymerase of genotypes A and/or C antigen, at least one HBX protein of genotypes A and/or C antigen, at least one HBV consensus core of genotypes A and/or C antigen, and at least one HBV consensus core MHCI and MHCII epitopes of genotypes A and/or C antigen. The invention encompasses these lentiviral vectors and lentiviral vector particles, methods of making the vectors, and their use, including medicinal uses. The lentiviral vectors and lentiviral vector particles are for use in administering to humans to induce immune responses against the HBV antigens.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: December 15, 2020
    Assignee: THERAVECTYS
    Inventors: Mohamad Jamiluddin, Ana Bejanariu, Emeline Sarry
  • LENTIVIRAL VECTORS FOR EXPRESSION OF HEPATITIS B VIRUS (HBV) ANTIGENS
    Publication number: 20190160166
    Abstract: The invention relates to nucleic acids, including lentiviral vectors and lentiviral vector particles, encoding at least one Hepatitis B virus (HBV) envelop surface of genotypes A and/or C antigen, at least one polymerase of genotypes A and/or C antigen, at least one HBX protein of genotypes A and/or C antigen, at least one HBV consensus core of genotypes A and/or C antigen, and at least one HBV consensus core MHCI and MHCII epitopes of genotypes A and/or C antigen. The invention encompasses these lentiviral vectors and lentiviral vector particles, methods of making the vectors, and their use, including medicinal uses. The lentiviral vectors and lentiviral vector particles are for use in administering to humans to induce immune responses against the HBV antigens.
    Type: Application
    Filed: July 20, 2017
    Publication date: May 30, 2019
    Inventors: Mohamad JAMILUDDIN, Ana BEJANARIU, Emeline SARRY